Injection timing for Retatrutide is flexible since the half-life extends well beyond one week
Yes, based on current trial data, retatrutide produces significantly more weight loss than Ozempic
Millions of people are already used to the routine of injecting themselves once a week
Optometry Australia, which represents the largest community of optometrists in Australia, has said patients should not be unnecessarily alarmed by this update and do not need to stop taking a GLP-1 drug unless they have a change in their vision
doi:10.1136/bmj-2023-076410 Almandoz JP, Wadden TA, Tewksbury C, et al
Planning a Safe Exit Strategy From GLP-1 Therapy If you decide to stop GLP-1 treatment, gradual tapering is safer than abrupt discontinuation